Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125738111 | 12573811 | 1 | I | 20160627 | 20160720 | 20160720 | PER | US-PFIZER INC-2016322458 | PFIZER | 0.00 | F | Y | 83.00000 | KG | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125738111 | 12573811 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 1 DF, 2X/DAY; LOWEST DOSE, CAPSULE, TWICE A DAY ORALLY | 20235 | 1 | DF | CAPSULE, HARD | BID | ||||||
| 125738111 | 12573811 | 2 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125738111 | 12573811 | 3 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | UNK | 0 | |||||||||||
| 125738111 | 12573811 | 4 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125738111 | 12573811 | 1 | Neuralgia |
| 125738111 | 12573811 | 4 | Sleep disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125738111 | 12573811 | Disturbance in attention | |
| 125738111 | 12573811 | Dizziness | |
| 125738111 | 12573811 | Drug intolerance | |
| 125738111 | 12573811 | Fatigue | |
| 125738111 | 12573811 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |